Opportunity knocks: drug serialization in Europe and the US
Posted on February 24, 2017 by
Despite serialization presenting a challenge for drug manufacturers, it is also gives the industry a unique opportunity to improve patient safety, reduce costly problems associated with counterfeit medicines and preserve its reputation.
Over the next few weeks we’ll be sharing our pharmaceutical serialization blog series written by Zenith Technologies’ serialization director, Carlos Machado and SEA Vision’s senior R&D product manager, Matteo Barbieri.
The series offers an insight into how to comply with the newest regulations on time, on budget and with best practice execution. Next in the series we discuss ‘Safety first, drivers to serialization.’